ScholarIQanswers from OpenAlex

Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome

PaperCitations, authors & open-access status

Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome have?

ScholarIQcitation count

Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome has 70 citations in the OpenAlex counts ScholarIQ stores.

When was Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome published?

ScholarIQyear

Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome has 2011 year in the ScholarIQ index.

What is the open-access status of Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome?

ScholarIQoa status

Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome has closed oa status in the ScholarIQ index.

What is the DOI of Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome?

ScholarIQdoi

The DOI for Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome is on the source record.

What is the PMID of Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome?

ScholarIQpmid

The PMID for Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome is on the source record.

What is the OpenAlex record for Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome?

ScholarIQopenalex

The OpenAlex for Type D Personality, Self-Efficacy, and Medication Adherence Following an Acute Coronary Syndrome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial